What to Expect When Kroger Reports
Kroger is scheduled to release its most recent quarterly results before the markets open on Thursday.
All Work
Chris Lange
The FDA Crackdown on Teen Vaping Just Got Real
The FDA is cracking down on smoking, but not what is traditionally considered smoking. The agency is going after e-cigarette manufacturers, as teen smokers (vapers) have reached epidemic levels.
Is Vital Therapies Done?
Vital Thearpies shares were absolutely crushed on Wednesday after the company announced less-than-favorable results for its liver failure trial.
Why Gilead Is Banking Big on Hepatitis B and Rheumatoid Arthritis
Gilead shares were up handily on Wednesday after the company announced that it had entered into a strategic collaboration with Precision BioSciences.
Why Foamix Shares Are Booming
Foamix Pharmaceuticals shares were last seen up early on Wednesday after the company announced a solid performance in its late-stage trial for moderate-to-severe acne.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a positive day for the broad U.S. markets. Crude oil more than recovered from Monday in this session. The S&P 500 sectors were more or less split down the middle.
Why Endocyte’s Secondary Offering Is Actually Pushing the Stock Higher
Endocyte filed with the SEC for a secondary offering. In most cases where a company does this, we see the stock drop. However, in this case investors are cheering Endocyte and its secondary offering.
Has Francesa’s Hit Rock Bottom Yet?
After Francesca’s released its most recent quarterly results on Tuesday, shares dropped to their lowest level ever since the company has been public.
Why USA Technologies Is Getting Crushed
USA Technologies shares dropped early on Tuesday after the company announced that it will not be filing its annual report (10-K form) for its fiscal year ended June 30, 2018, by the required September…
Will the IDT Acquisition Actually Go Through?
Integrated Device Technology shares hit a multiyear high early on Tuesday after it was announced that the Japanese semiconductor firm Renesas Electronics would be acquiring it.
Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
Why Wedbush Is Bucking the Trend on Snap
Snap shares made a handy gain early Tuesday after one key analyst decided to upgrade the stock. Is this the signal for a long-awaited turnaround?
Sonos: Why Its First Public Quarter Doesn’t Sound Right
Why Sonos shares tumbled after the release of its fiscal third-quarter financial results.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a mixed day for the broad U.S. markets. Crude oil took a small step back in the session. The S&P 500 sectors were almost entirely positive.
What to Expect When Sonos Reports After the Close
Sonos is scheduled to release its fiscal third-quarter financial results after the markets close on Thursday.
Bank7 Announces Potential Pricing for IPO
Bank7 intends to price more than 3 million shares to result in an initial public offering valued up to more than $80 million.
Alibaba Sets Up Succession Plan for Jack Ma
Alibaba shares dipped on Monday after the Chinese e-commerce giant announced a succession plan for Founder and Executive Chair Jack Ma.
Why Fred’s Shares Are Skyrocketing
Fred’s shares exploded on Monday after the company announced a definitive asset purchase agreement with Walgreens Boots Alliance.
Snap’s Newest Change to Executive Leadership
Snap shares took a small step back on Monday after the company announced that there would be a change to its executive leadership team. The company’s chief strategy officer, Imran Khan, is leaving the…
Why Endocyte Shares Are Booming
Endocyte shares made a solid gain early on Monday after the company announced an update from the FDA.